U6 small nuclear RNA 572, pseudogene (RNU6-572P)

RNU6-572P is classified as a **pseudogene** of the **U6 small nuclear RNA (snRNA)** gene family. U6 snRNA is essential in eukaryotic cells, where it forms part of the spliceosome—the complex responsible for the excision of introns from precursor mRNA during splicing[1][3]. Pseudogenes like RNU6-572P are characterized by high sequence similarity to the functional U6 genes but contain mutations or structural variations rendering them nonfunctional: they do not produce a functional RNA or protein product, nor do they participate in typical U6 snRNA roles in the spliceosome. The human genome contains many U6 pseudogenes, thought to be "back-ups" or relics from gene duplication and retrotransposition events[1][4]. While other pseudogenes have sometimes been found to modulate gene expression by acting as competitive endogenous RNAs (ceRNAs) or miRNA decoys, there is no published evidence to suggest RNU6-572P possesses any such regulatory activity or disease association[2]. RNU6-572P is **not a therapeutic target**: it does not encode a protein, is not a receptor or enzyme, and has no known pharmacological relevance. There are no known drugs, biomarkers, or safety concerns associated with this pseudogene. In sum, RNU6-572P is a non-coding RNA pseudogene, sometimes annotated in genomic databases but not functionally or clinically relevant.

Other names

RNU6-572PRNA, U6 small nuclear 572, pseudogene